Zdrowie i gospodarka · 13/08/2024

FDA Renewal of Peripheral and Central Nervous System Drugs Advisory Committee

The US Food and Drug Administration (FDA) is renewing the Peripheral and Central Nervous System Drugs Advisory Committee for an additional 2 years, with the new charter set to expire on June 4, 2026, following a determination by the Commissioner of Food and Drugs.